MENU
OGEN
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Oragenics (OGEN) Ownership - Who owns Oragenics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
1990 Main Street
Phone
+1 813 286-7900
Employees
5
Web
https://www.oragenics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.83M
P/E Ratio
N/A
Total Cash
1.35M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.26
Dividend Yield
N/A
Total Cash/Share
0.12
Total Debt/Equity
0.57
Revenue/Share
null USD as % of share price
Fundamentals
OGEN
Capitalization
3.83M
P/E Ratio
N/A
Risk (Beta)
1.26
Dividend Yield
N/A
Total Cash
1.35M
Total Cash/Share
0.12
Total Debt
0
Total Debt/Equity
0.57
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-266.33K
P/B Ratio
7.56
Cash Flow
N/A
Earnings
-7.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5.58K
Current Ratio
1.17
Current Revenue Per Employee
16391.13
Dividends Per Share - Security
N/A
EBITDA
-19.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
65.70
Revenue To Assets
-349.31
Shares Held By Institutions
183K
Shares Outstanding - Current
11.3M
Total Liabilities
1.38M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-93.530
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1990 Main Street
Phone
+1 813 286-7900
Employees
5
Web
https://www.oragenics.com